Chinese Journal of Dermatology ›› 2024, Vol. 57 ›› Issue (2): 134-140.doi: 10.35541/cjd.20230503
• Original Articles • Previous Articles Next Articles
Ma Guangrong1, Xie Hongfu1, Liu Jiashuang2, Zhou Zhonglian1, Zou Songqi1, Huang Yingxue1, Li Ji1
Received:
2023-09-01
Revised:
2024-01-17
Online:
2024-02-15
Published:
2024-02-01
Contact:
Huang Yingxue
E-mail:huangyingxue@csu.edu.cn
Ma Guangrong, Xie Hongfu, Liu Jiashuang, Zhou Zhonglian, Zou Songqi, Huang Yingxue, Li Ji. Small intestinal bacterial overgrowth in patients with rosacea: prevalence and clinical features[J]. Chinese Journal of Dermatology, 2024, 57(2): 134-140.doi:10.35541/cjd.20230503
[1] | 中华医学会皮肤性病学分会玫瑰痤疮研究中心, 中国医师协会皮肤科医师分会玫瑰痤疮专业委员会. 中国玫瑰痤疮诊疗指南(2021版)[J]. 中华皮肤科杂志, 2021,54(4):279⁃288. doi: 10.35541/cjd.20201078. |
[2] | Li J, Wang B, Deng Y, et al. Epidemiological features of rosacea in Changsha, China: a population⁃based, cross⁃sectional study[J]. J Dermatol, 2020,47(5):497⁃502. doi: 10.1111/1346⁃8138. 15301. |
[3] | Rainer BM, Kang S, Chien AL. Rosacea: epidemiology, pathogenesis, and treatment[J]. Dermatoendocrinol, 2017,9(1):e1361574. doi: 10.1080/19381980.2017.1361574. |
[4] | Stokes JH, Pillsbury DH. The effect on the skin of emotional and nervous states: theoretical and practical consideration of a gastro⁃intestinal mechanism [J]. Arch Derm Syphilol, 1930, 22(6): 962⁃993. doi: 10.1001/archderm.1930.01440180008002. |
[5] | Kim M, Choi KH, Hwang SW, et al. Inflammatory bowel disease is associated with an increased risk of inflammatory skin diseases: a population⁃based cross⁃sectional study[J]. J Am Acad Dermatol, 2017,76(1):40⁃48. doi: 10.1016/j.jaad.2016.08. 022. |
[6] | Egeberg A, Weinstock LB, Thyssen EP, et al. Rosacea and gastrointestinal disorders: a population⁃based cohort study[J]. Br J Dermatol, 2017,176(1):100⁃106. doi: 10.1111/bjd.14930. |
[7] | Jørgensen AR, Egeberg A, Gideonsson R, et al. Rosacea is associated with Helicobacter pylori: a systematic review and meta⁃analysis[J]. J Eur Acad Dermatol Venereol, 2017,31(12):2010⁃2015. doi: 10.1111/jdv.14352. |
[8] | Shah A, Morrison M, Burger D, et al. Systematic review with meta⁃analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease[J]. Aliment Pharmacol Ther, 2019,49(6):624⁃635. doi: 10.1111/apt.15133. |
[9] | Rezaie A, Buresi M, Lembo A, et al. Hydrogen and methane⁃based breath testing in gastrointestinal disorders: the North American Consensus[J]. Am J Gastroenterol, 2017,112(5):775⁃784. doi: 10.1038/ajg.2017.46. |
[10] | Bures J, Cyrany J, Kohoutova D, et al. Small intestinal bacterial overgrowth syndrome[J]. World J Gastroenterol, 2010,16(24):2978⁃2990. doi: 10.3748/wjg.v16.i24.2978. |
[11] | Grace E, Shaw C, Whelan K, et al. Review article: small intestinal bacterial overgrowth⁃⁃prevalence, clinical features, current and developing diagnostic tests, and treatment[J]. Aliment Pharmacol Ther, 2013,38(7):674⁃688. doi: 10.1111/apt.12456. |
[12] | Pimentel M, Saad RJ, Long MD, et al. ACG clinical guideline: small intestinal bacterial overgrowth[J]. Am J Gastroenterol, 2020,115(2):165⁃178. doi: 10.14309/ajg.0000000000000501. |
[13] | Salem I, Ramser A, Isham N, et al. The gut microbiome as a major regulator of the gut⁃skin axis[J]. Front Microbiol, 2018,9:1459. doi: 10.3389/fmicb.2018.01459. |
[14] | Wang FY, Chi CC. Rosacea, germs, and bowels: a review on gastrointestinal comorbidities and gut⁃skin axis of rosacea[J]. Adv Ther, 2021,38(3):1415⁃1424. doi: 10.1007/s12325⁃021⁃01624⁃x. |
[15] | Mahmud MR, Akter S, Tamanna SK, et al. Impact of gut microbiome on skin health: gut⁃skin axis observed through the lenses of therapeutics and skin diseases[J]. Gut Microbes, 2022,14(1):2096995. doi: 10.1080/19490976.2022.2096995. |
[16] | O′Neill CA, Monteleone G, McLaughlin JT, et al. The gut⁃skin axis in health and disease: a paradigm with therapeutic implications[J]. Bioessays, 2016,38(11):1167⁃1176. doi: 10. 1002/bies.201600008. |
[17] | Gaboriau⁃Routhiau V, Rakotobe S, Lécuyer E, et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses[J]. Immunity, 2009,31(4):677⁃689. doi: 10.1016/j.immuni.2009.08.020. |
[18] | Abhishek S, Palamadai Krishnan S. Epidermal differentiation complex: a review on its epigenetic regulation and potential drug targets[J]. Cell J, 2016,18(1):1⁃6. doi: 10.22074/cellj.2016. 3980. |
[19] | Maslowski KM, Vieira AT, Ng A, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43[J]. Nature, 2009,461(7268):1282⁃1286. doi: 10.1038/nature08530. |
[20] | Szántó M, Dózsa A, Antal D, et al. Targeting the gut⁃skin axis⁃probiotics as new tools for skin disorder management?[J]. Exp Dermatol, 2019,28(11):1210⁃1218. doi: 10.1111/exd.14016. |
[21] | Nam JH, Yun Y, Kim HS, et al. Rosacea and its association with enteral microbiota in Korean females[J]. Exp Dermatol, 2018,27(1):37⁃42. doi: 10.1111/exd.13398. |
[22] | Chen YJ, Lee WH, Ho HJ, et al. An altered fecal microbial profiling in rosacea patients compared to matched controls[J]. J Formos Med Assoc, 2021,120(1 Pt 1):256⁃264. doi: 10.1016/j.jfma.2020.04.034. |
[23] | Parodi A, Paolino S, Greco A, et al. Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication[J]. Clin Gastroenterol Hepatol, 2008,6(7):759⁃764. doi: 10. 1016/j.cgh.2008.02.054. |
[24] | Weinstock LB, Steinhoff M. Rosacea and small intestinal bacterial overgrowth: prevalence and response to rifaximin[J]. J Am Acad Dermatol, 2013,68(5):875⁃876. doi: 10.1016/j.jaad. 2012.11.038. |
[25] | Gravina A, Federico A, Ruocco E, et al. Helicobacter pylori infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea[J]. United European Gastroenterol J, 2015,3(1):17⁃24. doi: 10.1177/2050640614559262. |
[26] | Mohammadzadeh R, Mahnert A, Duller S, et al. Archaeal key⁃residents within the human microbiome: characteristics, interactions and involvement in health and disease[J]. Curr Opin Microbiol, 2022,67:102146. doi: 10.1016/j.mib.2022.102146. |
[27] | Chibani CM, Mahnert A, Borrel G, et al. A catalogue of 1,167 genomes from the human gut archaeome[J]. Nat Microbiol, 2022,7(1):48⁃61. doi: 10.1038/s41564⁃021⁃01020⁃9. |
[28] | Miller TL, Wolin MJ, Conway de Macario E, et al. Isolation of Methanobrevibacter smithii from human feces[J]. Appl Environ Microbiol, 1982,43(1):227⁃232. doi: 10.1128/aem.43.1.227⁃232.1982. |
[29] | Hoegenauer C, Hammer HF, Mahnert A, et al. Methanogenic archaea in the human gastrointestinal tract[J]. Nat Rev Gastroenterol Hepatol, 2022,19(12):805⁃813. doi: 10.1038/s41575⁃022⁃00673⁃z. |
[30] | Blais Lecours P, Duchaine C, Taillefer M, et al. Immunogenic properties of archaeal species found in bioaerosols[J/OL]. PLoS One, 2011,6(8):e23326. doi: 10.1371/journal.pone.0023326. |
[31] | Verma R, Verma AK, Ahuja V, et al. Real⁃time analysis of mucosal flora in patients with inflammatory bowel disease in India[J]. J Clin Microbiol, 2010,48(11):4279⁃4282. doi: 10. 1128/JCM.01360⁃10. |
[32] | Yamabe K, Maeda H, Kokeguchi S, et al. Distribution of archaea in Japanese patients with periodontitis and humoral immune response to the components[J]. FEMS Microbiol Lett, 2008,287(1):69⁃75. doi: 10.1111/j.1574⁃6968.2008.01304.x. |
[33] | Samuel BS, Hansen EE, Manchester JK, et al. Genomic and metabolic adaptations of Methanobrevibacter smithii to the human gut[J]. Proc Natl Acad Sci U S A, 2007,104(25):10643⁃10648. doi: 10.1073/pnas.0704189104. |
[34] | Bang C, Weidenbach K, Gutsmann T, et al. The intestinal archaea Methanosphaera stadtmanae and Methanobrevibacter smithii activate human dendritic cells[J/OL]. PLoS One, 2014,9(6):e99411. doi: 10.1371/journal.pone.0099411. |
[35] | Jun YK, Yu DA, Han YM, et al. The relationship between rosacea and inflammatory bowel disease: a systematic review and meta⁃analysis[J]. Dermatol Ther (Heidelb), 2023,13(7):1465⁃1475. doi: 10.1007/s13555⁃023⁃00964⁃6. |
[36] | Wu YB, Li XJ, Chen SY, et al. Inflammatory bowel disease and rosacea: a two⁃sample mendelian randomization study[J]. Dermatologic Therapy, 2023. doi: 10.1155/2023/1353823. |
[1] | Zhang Yue, Tao Meng, Li Min, Jiang Peiyu, Liu Yunyi, Liu Yixuan, Pan Ruoxin, Xu Yang. Severity assessment criteria for rosacea [J]. Chinese Journal of Dermatology, 2024, 57(2): 182-185. |
[2] | Pan Ruoxin, Gu Duoduo, Zhang Yue, Li Min, Tao Meng, Xu Yang. Metabolomics in rosacea [J]. Chinese Journal of Dermatology, 2024, 57(2): 178-181. |
[3] | Wei Ziyu, Yang Yong. Role of ion channels in the pathogenesis of rosacea [J]. Chinese Journal of Dermatology, 2024, 57(2): 174-177. |
[4] | Liu Tingwei, Meng Xiaoqi, Gu Duoduo, Pan Ruoxin, Zhang Yue, Xu Yang. Advances in the pathogenesis of rosacea [J]. Chinese Journal of Dermatology, 2024, 57(2): 186-190. |
[5] | Li Ji, Xie Hongfu. How to avoid misdiagnosis of rosacea [J]. Chinese Journal of Dermatology, 2024, 57(2): 119-122. |
[6] | Jiang Xian, Song Deyu. Insights into rosacea from the perspective of psychosomatic medicine [J]. Chinese Journal of Dermatology, 2024, 57(2): 123-126. |
[7] | Na Jun, Li Ruoyu, Zhong Shaomin, Yang Li, Wu Yan. Diagnosis and treatment of rosacea in the real world: a survey on the current status [J]. Chinese Journal of Dermatology, 2024, 57(2): 127-133. |
[8] | Zhang Xiaodong, Wang Manya, Zhu Yingjie, Luo Tiande, Liu Xiaoming. Application of fluorescence staining in the detection of Demodex mites in the facial skin [J]. Chinese Journal of Dermatology, 2023, 56(8): 766-769. |
[9] | Tao Meng, Li Min, Liu Yixuan, Liu Yunyi, Jiang Peiyu, Zhang Jiawen, Nan Yuqing, Xu Yang. Correlation between rosacea and neuropsychiatric diseases [J]. Chinese Journal of Dermatology, 2023, 56(7): 693-697. |
[10] | Mi Shuhong, Yu Yanqin, Hao Jinqi, Li Wei, Zhang Yang, Jia Ximei, Huang Yuxian, Sun Huaiyu, Shi Jihai. Analysis of imaging characteristics of papulopustular rosacea by high-frequency ultrasound combined with color Doppler flow imaging [J]. Chinese Journal of Dermatology, 2023, 56(6): 540-544. |
[11] | Li Jiaqi, Ye Feng, Ju Qiang. Symbiotic homeostasis of Staphylococcus epidermidis is associated with common skin disorders [J]. Chinese Journal of Dermatology, 2023, 56(5): 459-462. |
[12] | Li Rong, Zhang Jiaan, Chen Kun. Photoelectric therapy for rosacea [J]. Chinese Journal of Dermatology, 2023, 56(5): 468-470. |
[13] | Wang Xiaoyan, Zhang Jiawen, Liu Yunyi, Liu Yixuan, Jiang Peiyu, Li Min, Tao Meng, Xu Yang. Skin imaging and noninvasive measurements of rosacea [J]. Chinese Journal of Dermatology, 2023, 56(4): 361-364. |
[14] | Chen Lianghong, Sun Yan, Wang Jingyu, Wu Yan. Benvitimod for the treatment of dermatoses [J]. Chinese Journal of Dermatology, 2023, 0(2): 20210875-e20210875. |
[15] | Sun Jing, Xu Yingnan, Lin Tong, Xue Jinsong. Analysis of clinical treatment outcomes of ocular lesions in 28 cases of severe ocular rosacea [J]. Chinese Journal of Dermatology, 2023, 56(2): 142-145. |
|